Christian Kittel

Title: Christian Kittel: Innovator in Influenza Virus Technology

Introduction

Christian Kittel is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of virology, particularly in the development of innovative viral vectors for vaccine production.

Latest Patents

Kittel holds a patent for a "Replication deficient influenza virus for the expression of heterologous sequences." This invention relates to a novel replication deficient influenza virus that includes a modified NS1 segment. The NS1 protein is designed to lack a functional RNA binding domain and functional effector domain, with a heterologous sequence inserted between the splice donor site and the splice acceptor site of the NS gene segment. This virus can be utilized as a vector for the expression of various proteins, including chemokines, cytokines, or antigenic structures, and is instrumental in vaccine production. Additionally, the patent includes a fusion peptide that comprises part of the N-terminus of an NS1 protein and a signal sequence fused to the C-terminus of the NS1 peptide.

Career Highlights

Throughout his career, Christian Kittel has worked with prominent companies in the biotechnology sector, including Baxalta GmbH and Nanotherapeutics, Inc. His work has focused on advancing the understanding and application of viral technologies in therapeutic contexts.

Collaborations

Kittel has collaborated with several professionals in his field, including Markus Wolschek and Andrej Egorov. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Christian Kittel is a pioneering inventor whose work in the field of influenza virus technology has the potential to impact vaccine development significantly. His innovative approaches and collaborations continue to drive advancements in virology and biotechnology.